Trial intelligence / Profile preview

Gene expression in oocytes during four ovulation stimulation protocols

IRCT20101115005181N16Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label trial of gonadotropin-releasing hormone agonist and follicle-stimulating hormone in female infertility (4 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Egg maturation, Fertilization success rate and 2 more. Started Jun 2020; status: completed.

02

Drugs

gonadotropin-releasing hormone agonistfollicle-stimulating hormone
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20101115005181N16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20101115005181N16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call